Stockhub

Zelira Therapeutics Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 August 2022

14 August 2022

31 July 2022

  • curprev 21:4621:46, 31 July 2022‎ Chris talk contribs‎ 1,162 bytes +1,162‎ Created page with "Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based medicines for the treatment of various medical conditions in Australia. The company is also involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diab..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Zelira_Therapeutics_Limited’